Genome-wide association study of antipsychotic-induced QTc interval prolongation

K Åberg, DE Adkins, Y Liu, JL McClay… - The …, 2012 - nature.com
QT prolongation is associated with increased risk of cardiac arrhythmias. Identifying the
genetic variants that mediate antipsychotic-induced prolongation may help to minimize this …

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study

Z Lu, Y Zhang, H Yan, Y Su, L Guo, Y Liao, T Lu… - Translational …, 2022 - nature.com
QTc interval prolongation is one of the most common antipsychotic-induced side effects
which could lead to ventricular tachycardia or Torsade de Pointes, even cardiac arrest …

Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia

S Volpi, C Heaton, K Mack, JB Hamilton… - Molecular …, 2009 - nature.com
Administration of certain drugs (for example, antiarrhythmics, antihistamines, antibiotics,
antipsychotics) may occasionally affect myocardial repolarization and cause prolongation of …

Corrected QT interval prolongation in psychopharmacological treatment and its modulation by genetic variation

F Corponi, C Fabbri, G Boriani, I Diemberger… - …, 2019 - karger.com
Several antipsychotics and antidepressants have been associated with electrocardiogram
alterations, the most clinically relevant of which is the heart rate-corrected QT interval (QT c) …

QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors

I Spellmann, MA Reinhard, D Veverka, P Zill… - European Archives of …, 2018 - Springer
Antipsychotics are effective in treating schizophrenia but may lead to a higher
cardiovascular risk due to QTc prolongation. Besides drugs, genetic and clinical factors may …

Genetic factors contribute to medication-induced QT prolongation: a review

T Toba-Oluboka, PG Tibbo, K Dempster, M Alda - Psychiatry Research, 2022 - Elsevier
QT prolongation is a heart rhythm condition that impacts the lives of many people and when
severe can be life-threatening. QT prolongation has been linked to variations in several …

Pharmacogenetics of drug-induced QT interval prolongation: an update

MN Niemeijer, ME van den Berg, M Eijgelsheim… - Drug safety, 2015 - Springer
A prolonged QT interval is an important risk factor for ventricular arrhythmias and sudden
cardiac death. QT prolongation can be caused by drugs. There are multiple risk factors for …

Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval

CL Avery, CM Sitlani, DE Arking, DK Arnett… - The …, 2014 - nature.com
Variability in response to drug use is common and heritable, suggesting that genome-wide
pharmacogenomics studies may help explain the 'missing heritability'of complex traits. Here …

Common genetic variant risk score is associated with drug-induced QT prolongation and torsade de pointes risk: a pilot study

DG Strauss, J Vicente, L Johannesen, K Blinova… - Circulation, 2017 - Am Heart Assoc
Background: Drug-induced QT interval prolongation, a risk factor for life-threatening
ventricular arrhythmias, is a potential side effect of many marketed and withdrawn …

Systems pharmacology of arrhythmias

SI Berger, A Ma'ayan, R Iyengar - Science signaling, 2010 - science.org
Long-QT syndrome (LQTS) is a congenital or drug-induced change in electrical activity of
the heart that can lead to fatal arrhythmias. Mutations in 12 genes encoding ion channels …